Gastrointestinal Stromal Tumor (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
Condition: Gastrointestinal Stromal Tumors Intervention: Drug: Imatinib Mesylate Sponsor: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials
Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
Condition: Gastrointestinal Stromal Tumors Interventions: Drug: Avapritinib; Drug: Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al ) Sponsor: CStone Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2022 Category: Research Source Type: clinical trials
